Download Citation
Article Source:
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm
Artigas L,
Coma M,
Matos-Filipe P,
Aguirre-Plans J,
Farrés J,
et al.
(2020)
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
PLOS ONE 15(10): e0240149.
https://doi.org/10.1371/journal.pone.0240149